A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)

NCT00127192 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

363

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: sitagliptin phosphate
DRUG: Comparator: placebo (unspecified)

Sponsor

Merck Sharp & Dohme LLC